References
- Aljuffali IA, Sung CT, Shen F-M, Huang C-T, Fang J-Y. 2014. Erratum to: squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J. 16:140–150.
- Azar RP, Thomas AH, Maurer M, Lindner G. 2016. Alterations in hair follicle morphology and hair shaft production after follicular unit transplantation. Am J Dermatopathol. 38:732–738.
- Blume-Peytavi U, Kunte C, Krisp A, Bartels NG, Ellwanger U, Hoffmann R. 2007. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. JDDG. 5:391–395.
- Inui S, Itami S. 2013. Androgen actions on the human hair follicle: perspectives. Exp Dermatol. 22:168–171.
- Irwig MS, Kolukula S. 2011. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 8:1747–1753.
- Orsi DD, Pellegrini M, Pichini S, Mattioli D, Marchei E, Gagliardi L. 2008. High-performance liquid chromatography–diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases. J Pharm Biomed Anal. 48:641–648.
- Patel B, Velasco MAM, Gutierrez FT, Khesin D. 2017. Addressing androgenetic Alopecia-A complex disorder-with a multilateral treatment strategy. J Bioequiv Bioavail. 3:1–9.
- Patterson SC, Ramstad T, Mills KA. 2005. Development and validation of a procedure for the determination of minoxidil in hair-regrowth formulations using two variants of capillary zone electrophoresis. Il Farmaco. 60:547–554.
- Pereira MN, Schulte HL, Duarte N, Lima EM, Sá-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho MS. 2017. Solid effervescent formulations as new approach for topical minoxidil delivery. Eur J Pharm Sci. 96:411–419.
- Phapale PB, Lee HW, Lim MS, Kim EH, Kim SD, Park J, Lee M, Hwang SK, Yoon YR. 2010. Determination of finasteride in human plasma by UPLC-MS/MS and its application to clinical pharma-cokinetic study. J Chromatogr B: Anal Technol Biomed Life Sci. 878:1718–1723.
- Ptáce P, Macek J, Klíma J. 2000. Determination of finasteride in human plasma by liquid-liquid extraction and high-performance liquid chromatography. J Chromatogr B: Biomed Sci Appl. 738:305–310.
- Rao Y, Zheng F, Liang X, Wang H, Zhang J, Lu X. 2015. Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers. Drug Deliv. 22:1003–1009.
- Sheikh S, Ahmad A, Ali SM, Ahmad MU, Paithankar M, Saptarshi D, Kale P, Maheshwari K, Barkate HV, Pathak HL, et al. 2015. A new topical formulation of minoxidil and finasteride improves hair growth in men with androgenetic alopecia. J Clin Exp Dermatol Res. 6:253.
- Shi C, Chen Z, Chen Y, Yu R. 2015. Quantitative analysis of hormones in cosmetics by LC-MS/MS combined with an advanced calibration model. Anal Methods. 7:6804–6809.
- Sinclair R, Wewerinke M, Jolley D. 2005. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 152:466–473.
- Sinclair RD, Dawber RD. 2001. Androgenetic alopecia in men and side effects in women. Clin Dermatol. 19:167–178.
- Wang J, Chen B, Yao S. 2008. Analysis of six synthetic adulterants in herbal weight- reducing dietary supplements by LC electrospray ionization-MS. Food Addit Contam A. 25:822–830.
- Wessagowit V, Tangjaturonrusamee C, Kootiratrakarn T, Bunnag T, Pimonrat T, Muangdang N, Pichai P. 2016. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract. Australasian J Dermatol. 57:76–82.
- Yazdabadi A, Sinclair R. 2011. Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. Aust J Dermatol. 52:132–134.
- Yuan R, Lin Y. 2000. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther. 86:191–198.